norethindrone has been researched along with 2-hydroxyestradiol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
Guzman, RC; Nandi, S; Rajkumar, L; Talamantes, F; Thordarson, G; Yang, J | 1 |
Brosnan, JF; Kelly, LA; Norris, LA; O'Leary, JJ; Sheppard, BL | 1 |
1 review(s) available for norethindrone and 2-hydroxyestradiol
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
3 other study(ies) available for norethindrone and 2-hydroxyestradiol
Article | Year |
---|---|
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments.
Topics: 2-Methoxyestradiol; Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Estradiol; Estriol; Estrogens; Ethinyl Estradiol; Female; Mammary Neoplasms, Animal; Megestrol Acetate; Methylnitrosourea; Norethindrone; Progesterone; Progestins; Rats; Rats, Inbred Lew; Tamoxifen; Time Factors; Treatment Outcome | 2004 |
Norethisterone acetate alters coagulation gene expression in vitro in human cell culture.
Topics: Blood Coagulation; Cells, Cultured; Contraceptives, Oral, Synthetic; Estradiol; Estrone; Factor VII; Fibrinogen; Gene Expression Regulation; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Prothrombin; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Time Factors; Tissue Plasminogen Activator | 2013 |